The critical care medicine department (ccmd) is in need of nitric oxide gas to treat critically ILL patient.
Active Awarded Last action
- Contract number
- 75N90024F00080
- Awardee
-
INO Therapeutics LLC UEI XXQHL619FUN6
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $115,000
Award facts
- Opportunity
-
- RFQ1704890 Solicitation number
- Contract value 100% obligated
- $115,000.00 Current and potential, with all options
- Completion date 87% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Hampton, NJ 08827, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $40,000 | |
| Funding Only Action | $10,000 | |
| Exercise an Option | $40,000 | |
| Original award | $25,000 |
About this award
The National Institutes of Health Clinical Center awarded a $115,000 delivery order to INO Therapeutics LLC on July 1, 2024, to supply nitric oxide gas for treating critically ill patients in the Critical Care Medicine Department. The contract, which extends through February 28, 2027, is issued under a firm fixed-price structure with no small business set-aside designation. INO Therapeutics LLC, headquartered in Hazelwood, Missouri, specializes in providing inhaled nitric oxide therapeutic gases and respiratory therapy systems to federal healthcare agencies, including the Department of Veterans Affairs and Defense Health Agency. The delivery order is placed against the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB), with performance taking place in Hampton, New Jersey.
This delivery order represents a continuation of INO Therapeutics' established role as a critical supplier of specialized medical gases to the federal healthcare system. The company maintains an extensive contract portfolio across multiple Veterans Integrated Service Networks and federal medical centers, with experience delivering nitric oxide gas supplies, INOMAX cylinders with delivery systems, and comprehensive inhalation therapy services. The vendor holds three active blanket purchase agreements that serve as parent vehicles for task order calls, including a Defense Health Agency BPA valued at $404,200 through March 2030 and a Veterans Affairs VISN 2 agreement valued at $789,408.92 through September 2027, enabling federal healthcare agencies to procure critical therapeutic gases on an as-needed basis to support patient care across neonatal, pediatric, and adult critical care populations.
Quick answers
Who was awarded contract 75N90024F00080?
75N90024F00080 was awarded to INO Therapeutics LLC by NIH Clinical Center (National Institutes of Health) on July 1, 2024.
How much is contract 75N90024F00080 worth?
The government has obligated $115,000 on 75N90024F00080.
Is contract 75N90024F00080 an order under another contract?
Yes. 75N90024F00080 is a delivery order under V797D60737, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75N90024F00080 competed?
The extent of competition for 75N90024F00080 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award